Stem Cell Therapy
Mar 28, 2026
1 min read
Polycystic Ovary Syndrome (PCOS) and Mesenchymal Stem Cell Research
Analyzing new therapeutic avenues using autologous stem cells to regulate endocrine pathways and restore ovulation in PCOS.
Understanding the PCOS Endocrine Profile
Polycystic Ovary Syndrome (PCOS) is a complex metabolic and endocrine disorder characterized by chronic anovulation, hyperandrogenism (elevated male hormones), and polycystic ovarian morphology on ultrasound. Conventional treatments focus on symptom management or ovulation induction. Our research explores regenerative approaches to treat the underlying dysfunction.
ASRM Presentation Findings
Mesenchymal stem cells (MSCs) possess strong immunomodulatory and paracrine properties. By localizing autologous MSCs within the ovarian environment, we aim to reduce local inflammation, decrease androgen secretion, and restore regular follicle maturation.
🧠 Key Takeaways
- ✅ PCOS metabolic dysfunction causes persistent anovulation.
- ✅ MSC therapy reduces inflammatory markers inside the ovary.
- ✅ Promotes regular recruitment of healthy follicles.
- ✅ Aims to reduce reliance on daily hormone pills.
